Overview
Weiyun Ai is an Oncologist in San Francisco, California. Dr. Ai has been practicing medicine for over 31 years and is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 63 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave, San Francisco, CA 94143
1701 Divisadero St, San Francisco, CA 94115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Stanford Health Care
Ranjana Advani is an Oncologist and a Hematologist in Stanford, California. Dr. Advani has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
Stanford Health Care
Elwyn Cabebe is an Oncologist and a Palliative Medicine provider in Stanford, California. Dr. Cabebe is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Stanford Health Care
Joseph Schroers-Martin is an Oncologist and a Hematologist in Stanford, California. Dr. Schroers-Martin is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Follicular Lymphoma, and Non-Hodgkin Lymphoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin Lymphoma
- T-Cell LymphomaDr. Ai isElite. Learn about T-Cell Lymphoma.
- Distinguished
- Anaplastic Large Cell LymphomaDr. Ai isDistinguished. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Ai isDistinguished. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Ai isDistinguished. Learn about B-Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Ai isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Ai isDistinguished. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Follicular LymphomaDr. Ai isDistinguished. Learn about Follicular Lymphoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Bone Marrow AspirationDr. Ai isAdvanced. Learn about Bone Marrow Aspiration.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Gastric LymphomaDr. Ai isAdvanced. Learn about Gastric Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloblastic Leukemia with Maturation
- AgranulocytosisDr. Ai isExperienced. Learn about Agranulocytosis.
- Brain TumorDr. Ai isExperienced. Learn about Brain Tumor.
- Burkitt LymphomaDr. Ai isExperienced. Learn about Burkitt Lymphoma.
- Childhood Acute Myeloid Leukemia